NM_001387283.1:c.4763delT
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001387283.1(SMARCA4):c.4763delT(p.Val1588AlafsTer40) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001387283.1 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA4 | NM_001387283.1 | c.4763delT | p.Val1588AlafsTer40 | frameshift_variant | Exon 34 of 36 | ENST00000646693.2 | NP_001374212.1 | |
SMARCA4 | NM_003072.5 | c.4667delT | p.Val1556AlafsTer40 | frameshift_variant | Exon 33 of 35 | ENST00000344626.10 | NP_003063.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.4763delT | p.Val1588AlafsTer40 | frameshift_variant | Exon 34 of 36 | NM_001387283.1 | ENSP00000495368.1 | |||
SMARCA4 | ENST00000344626.10 | c.4667delT | p.Val1556AlafsTer40 | frameshift_variant | Exon 33 of 35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
SMARCA4 | ENST00000643549.1 | c.4673delT | p.Val1558AlafsTer40 | frameshift_variant | Exon 33 of 35 | ENSP00000493975.1 | ||||
SMARCA4 | ENST00000541122.6 | c.4577delT | p.Val1526AlafsTer40 | frameshift_variant | Exon 33 of 35 | 5 | ENSP00000445036.2 | |||
SMARCA4 | ENST00000643296.1 | c.4577delT | p.Val1526AlafsTer40 | frameshift_variant | Exon 32 of 34 | ENSP00000496635.1 | ||||
SMARCA4 | ENST00000644737.1 | c.4577delT | p.Val1526AlafsTer40 | frameshift_variant | Exon 32 of 34 | ENSP00000495548.1 | ||||
SMARCA4 | ENST00000589677.5 | c.4574delT | p.Val1525AlafsTer40 | frameshift_variant | Exon 33 of 35 | 5 | ENSP00000464778.1 | |||
SMARCA4 | ENST00000643995.1 | c.4088delT | p.Val1363fs | frameshift_variant | Exon 30 of 32 | ENSP00000496004.1 | ||||
SMARCA4 | ENST00000644963.1 | c.3317delT | p.Val1106fs | frameshift_variant | Exon 26 of 28 | ENSP00000495599.1 | ||||
SMARCA4 | ENST00000644065.1 | c.3299delT | p.Val1100fs | frameshift_variant | Exon 25 of 27 | ENSP00000493615.1 | ||||
SMARCA4 | ENST00000642350.1 | c.3161delT | p.Val1054AlafsTer40 | frameshift_variant | Exon 25 of 27 | ENSP00000495355.1 | ||||
SMARCA4 | ENST00000643857.1 | c.2927delT | p.Val976fs | frameshift_variant | Exon 23 of 25 | ENSP00000494159.1 | ||||
SMARCA4 | ENST00000538456.4 | c.731delT | p.Val244fs | frameshift_variant | Exon 6 of 8 | 3 | ENSP00000495197.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Rhabdoid tumor predisposition syndrome 2 Pathogenic:1
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.4763delT pathogenic mutation, located in coding exon 33 of the SMARCA4 gene, results from a deletion of one nucleotide at nucleotide position 4763, causing a translational frameshift with a predicted alternate stop codon (p.V1588Afs*40). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This alteration has been observed in at least one individual with a personal and/or family history that is consistent with SMARCA4-related disease (Ambry internal data). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Loss-of-function variants in SMARCA4 are known to cause rhabdoid tumor predisposition syndrome including small cell carcinoma of the ovary-hypercalcemic type (SCCOHT); however, such associations with neurodevelopmental disorders are exceedingly rare (Kosho T et al. Am J Med Genet C Semin Med Genet. 2014 Sep;166C(3):262-75; Jelinic P et al. Nat Genet. 2014 May;46(5):424-6). Based on the supporting evidence, this alteration is pathogenic for rhabdoid tumor predisposition syndrome/SCCOHT; however, the association of this alteration with Coffin-Siris syndrome is unlikely. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at